Sienna stock still soaring after $65 million IPO

You are here: Home > Central Coast Health Watch > Current Article

Sienna stock still soaring after $65 million IPO

By Marissa Nall / Friday, August 4th, 2017 / Comments Off on Sienna stock still soaring after $65 million IPO

Shares for the region’s newest public company, Sienna Biopharmaceuticals, continued to climb after the stock jumped nearly 30 percent following its July 27 initial public offering. The Westlake Village biotechnology company closed with a big gain after it raised $65 million in its IPO, pricing the 4.33 million shares it offered at $15. Underwriters, including…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.